Market Cap : 1.63 B | Enterprise Value : 1.48 B | PE Ratio : | PB Ratio : 6.54 |
---|
NAS:TVTX has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:TVTX has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. Travere Therapeutics's net issuance of debt for the three months ended in Dec. 2020 was $0.0 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Dec. 2020 was $0.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.
Net Issuance of Debt for the trailing twelve months (TTM) ended in Dec. 2020 was 0 (Mar. 2020 ) + 0 (Jun. 2020 ) + 0 (Sep. 2020 ) + 0 (Dec. 2020 ) = $0.0 Mil.
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
No Headline